BAMCO Inc’s Astera Labs ALAB Stock Holding History

BAMCO Inc’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-500,000	Closed	-$37.1M	–	351
2024 Q1	$37.1M	Buy	+500,000	New	+$37M	0.1%	161

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Intel Corp Santa Clara, California $621M AUM 34.06% 1-Year Est. Return

Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return

BAMCO Inc's ALAB Position: Q2 2024 in Review

BAMCO Inc sold out of Astera Labs (ALAB) in Q2 2024, closing a stake of 500,000 shares — an estimated $37.1M sold.

BAMCO Inc first reported a position in ALAB in Q1 2024 and held it in 1 quarter. The position peaked at $37.1M in Q1 2024. 146 funds tracked by Wall St. Rank hold ALAB as of Q2 2024.

BAMCO Inc reported no remaining Astera Labs position as of Q2 2024 after selling out during the quarter.
BAMCO Inc sold 500,000 Astera Labs shares in Q2 2024, an estimated $37.1M.
BAMCO Inc first reported a position in Astera Labs in Q1 2024 and held it in 1 quarter.
BAMCO Inc's Astera Labs position peaked at $37.1M in Q1 2024.
146 funds tracked by Wall St. Rank held Astera Labs as of Q2 2024.

Based on BAMCO Inc's 13F filing for Q2 2024, filed 14 Aug 2024.